Michael B. Smith

The Ohio State University Wexner Medical Center

Also affiliated with The Ohio State University

MedicineChemistryBiochemistry, Genetics and Molecular BiologyPhysics and Astronomy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer”.

Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer

Investigational New Drugs(2025)10.1007/s10637-025-01591-y

N/A

0.165DataRank · unranked

2 citations

Ruohan Wu, Lai Wei, Mikhail M. Dikov, Shankar Suman, Po‐Lan Su +17 more